The University of California San Diego has been named the fourth best public university in the United States by the 2019 Academic Ranking of World Universities (ARWU). The rankings list the campus as the country’s 15th best university and 18th in the world.
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides a new and unexpected therapeutic target for new drug development.
Biologists have developed the first system for determining gene expression based on machine learning. Considered a type of Rosetta Stone, the new method leverages algorithms trained on a set of known plant genes. The method carries implications across biology, from drug discovery to plant breeding.
UC San Diego engineers have developed the thinnest optical device in the world: a waveguide that is three layers of atoms thin. The work is a proof of concept for scaling down optical devices to sizes that are orders of magnitude smaller than today’s devices.
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
